Magali Herrant
Impact in
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Platelet Disorders and Treatments
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Molecular Biology top 10%
- Cell death mechanisms and regulation
- Ubiquitin and proteasome pathways
- Melanoma and MAPK Pathways
Papers in
-
- Cell death mechanisms and regulation 5
-
- Escherichia coli research studies 1
- Co-authors
- Patrick Auberger (11 shared papers)Frédéric Luciano (6 shared papers)Arnaud Jacquel (5 shared papers)Pascal Colosetti (3 shared papers)Gilles Pagès (2 shared papers)Sébastien Cagnol (1 shared paper)Nathalie Belhacène (3 shared papers)Sandrine Marchetti (2 shared papers)
- Journals
- Oncogene (4 papers)The FASEB Journal (2 papers)Neurodegenerative Diseases (1 paper)European Journal of Immunology (1 paper)Leukemia (1 paper)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Magali Herrant
11 papers receiving 915 citations
Peers
Comparison fields: 5 of 59
- Hematology 107
- Molecular Biology 388
- Endocrinology 13
- Genetics 23
- Immunology 38
Countries citing papers authored by Magali Herrant
This map shows the geographic impact of Magali Herrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magali Herrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magali Herrant more than expected).
Fields of papers citing papers by Magali Herrant
This network shows the impact of papers produced by Magali Herrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magali Herrant. The network helps show where Magali Herrant may publish in the future.
Co-authors
The 25 scholars most cited alongside Magali Herrant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 417 | |
| 2 | 2004 | 154 | |
| 3 | 2003 | 110 | |
| 4 | 2005 | 72 | |
| 5 | 2002 | 41 | |
| 6 | 2006 | 34 | |
| 7 | 2002 | 28 | |
| 8 | 2004 | 26 | |
| 9 | 2003 | 23 | |
| 10 | 2002 | 19 | |
| 11 | 2007 | 3 |
About Magali Herrant
Magali Herrant is a scholar working on Molecular Biology, Endocrinology, Hematology, Neurology and Immunology, having authored 11 papers that have together received 927 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), T-cell and B-cell Immunology (1 paper), Escherichia coli research studies (1 paper), Parkinson's Disease Mechanisms and Treatments (1 paper), Alzheimer's disease research and treatments (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Hematology (107 citations), Molecular Biology (388 citations), Endocrinology (13 citations), Genetics (23 citations) and Immunology (38 citations). Magali Herrant has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Patrick Auberger, Frédéric Luciano, Arnaud Jacquel, Pascal Colosetti, Gilles Pagès, Sébastien Cagnol, Nathalie Belhacène, Sandrine Marchetti, Paul M Hofman and Laurence Legros. Their work appears in journals such as Oncogene, The FASEB Journal, Neurodegenerative Diseases, European Journal of Immunology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.